Court largely rejects patentee's proposed claim constructions

Posted on September 29, 2008 by Morris James LLP

Amgen, Inc., et al. v. Ariad Pharmaceuticals, Inc., et al., C.A. No. 06-259-MPT, September 19, 2008.

Thynge, M.J. The Court issues a claim construction ruling following Markman Hearing.

Plaintiff filed declaratory judgment action asserting that U.S. Patent No. 6,410,516 is invalid and not infringed.  The patented technology relates to Nuclear Factors Associated with Transcriptional Regulation.  The Court conducted a Markman Hearing on June 19, 2008.  The Order sets forth the Court’s construction of those claims adopting in large part Amgen’s proposed constructions.

 
Tags: , , ,
Trackbacks (0) Links to blogs that reference this article Trackback URL
http://depatentlaw.morrisjames.com/admin/trackback/126823
Comments (0) Read through and enter the discussion with the form at the end
Post A Comment / Question Use this form to add a comment to this entry.







Remember personal info?
Send To A Friend Use this form to send this entry to a friend via email.